Accéder au contenu
Merck

Flumazenil--treatment or toxin.

Journal of toxicology. Clinical toxicology (2004-06-25)
Donna L Seger
RÉSUMÉ

Flumazenil is frequently administered to the poisoned patient. Seizures may be precipitated and resedation may occur in patients who awakened following flumazenil administration. Seizures may increase morbidity and mortality of the overdose. Benefit:Risk ratio of administering flumazenil should be determined in each overdose patient. Indications for flumazenil are limited.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Flumazenil, >99% (HPLC), solid